Skip to Content

Clinical Trials Details

GOG 0277

Patient Information

GOG 0277 - A Phase III Randomized Trail of Gemcitabine (NSC#613327 Plus Docetaxel (NSC# 628503) followed By Doxorubicin (NSC#123127) Versus Observation for Uterus Limited, High-Grade Uterine Leiomyosarcoma

Find out more information about clinical trial - GOG 0277

Clinical Trial Categories

  • Uterine Cancer


  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725


Directions: If entering campus from Huffman Mill Road then go straight until you come to a stop sign. At the stop sign go straight. Take your first right after the stop sign to enter Cancer Center parking lot. If you enter the hospital campus from Grand Oaks Boulevard then turn left after entering and take your first right into the Cancer Center parking lot. Once you enter the Cancer Center, go down the hallway on your right and the Large Conference Room is at the end of the hallway.

Also in this Section